Literature DB >> 6341902

Streptococci--are they different in New Zealand?

D R Martin, G E Meekin, L A Finch.   

Abstract

Rheumatic fever and acute glomerulonephritis resulting from group A streptococcal infection are important childhood illnesses in New Zealand particularly in certain geographical areas. A study of streptococcal serotypes occurring in infections during a three year period, May 1979-May 1982, has shown that many serotypes with well documented disease-association occur amongst New Zealand isolates. During the period of study disease-association of specific serotypes was demonstrated. Serotypes unique to New Zealand were not major contributors to disease patterns.

Entities:  

Mesh:

Year:  1983        PMID: 6341902

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

1.  Identification of sequence types among the M-nontypeable group A streptococci.

Authors:  W A Relf; D R Martin; K S Sriprakash
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 2.  Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature.

Authors:  Catherine S Marshall; Allen C Cheng; Peter G Markey; Rebecca J Towers; Leisha J Richardson; Peter K Fagan; Lesley Scott; Vicki L Krause; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

3.  Protective immunity to the group A Streptococcus may be only strain specific.

Authors:  S A de Malmanche; D R Martin
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

4.  Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia.

Authors:  D L Gardiner; K S Sriprakash
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

5.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.

Authors:  J M Musser; V Kapur; J Szeto; X Pan; D S Swanson; D R Martin
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.